Sangamo launches auction for pain program amid Chapter 11 proceedings

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. SPY
5. INTC
6. META
7. JBLU
8. ANT
9. AAPL
10. NVDA

Go back to Sangamo launches auction for pain program amid Chapter 11 proceedings

Sangamo Therapeutics Launches Auction Process for Clinical-Stage Chronic Neuropathic Pain Program

October 13, 2026 4:01 PM EDT

Auction process initiated for ST-503 program for chronic neuropathic pain, expected to be completed in fourth quarter of 2026

Previously announced asset sale transactions with PTC and Lilly have closed, generating $163.55 million in gross cash proceeds

RICHMOND, Calif., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (OTCID Basic Market: SGMOQ) today announced the new timeline for its continued sale process for the ST-503 program, a clinical-stage investigational epigenetic regulator for the treatment of intractable pain due to small fiber neuropathy (SFN).

... More